iShares Neuroscience and Healthcare ETF
Registrant
iShares Trust
Class ticker
Net Assets
$5,174,384
Holdings
58
Latest Report
Apr 30, 2026
Holdings · 58
Export CSV
Only this fund's positions in US-listed stocks Equibles tracks are shown. Other
holdings — bonds, foreign securities, and cash — aren't listed yet, so the positions
below are a fraction of the fund's
$5,174,384 in net assets.
Showing 1–50
of 58 holdings by value
· page 1 of 2
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc | XENE | 4,419 | $247,641 | 4.79% | Long | EC | |
| AXSOME THERAPEUTICS, INC. | AXSM | 1,144 | $237,666 | 4.59% | Long | EC | |
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | 3,103 | $228,008 | 4.41% | Long | EC | |
| ALKERMES PUBLIC LIMITED COMPANY | ALKS | 6,446 | $217,295 | 4.20% | Long | EC | |
| CENTESSA PHARMACEUTICALS PLC | CNTA | 5,186 | $204,432 | 3.95% | Long | — | |
| argenx SE | ARGX | 257 | $200,902 | 3.88% | Long | — | |
| PTC THERAPEUTICS, INC. | PTCT | 2,938 | $191,146 | 3.69% | Long | EC | |
| NEUROCRINE BIOSCIENCES, INC. | NBIX | 1,448 | $190,658 | 3.68% | Long | EC | |
| BIOGEN INC. | BIIB | 1,004 | $190,037 | 3.67% | Long | EC | |
| Scholar Rock Holding Corp | SRRK | 4,075 | $189,936 | 3.67% | Long | EC | |
| Praxis Precision Medicines Inc | PRAX | 594 | $189,385 | 3.66% | Long | EC | |
| ACADIA PHARMACEUTICALS INC. | ACAD | 8,328 | $186,964 | 3.61% | Long | EC | |
| Dianthus Therapeutics Inc | DNTH | 1,998 | $175,424 | 3.39% | Long | EC | |
|
CATALYST PHARMACEUTICALS, INC.
|
14888U101 | 6,048 | $170,130 | 3.29% | Long | EC | |
| Denali Therapeutics Inc | DNLI | 7,800 | $146,016 | 2.82% | Long | EC | |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | 3,000 | $144,000 | 2.78% | Long | EC | |
| Edgewise Therapeutics Inc | EWTX | 4,232 | $131,023 | 2.53% | Long | EC | |
| Dyne Therapeutics, Inc | DYN | 6,966 | $122,253 | 2.36% | Long | EC | |
| AxoGen, Inc. | AXGN | 2,800 | $120,960 | 2.34% | Long | EC | |
| SAREPTA THERAPEUTICS, INC. | SRPT | 5,480 | $114,422 | 2.21% | Long | EC | |
| Capricor Therapeutics Inc | CAPR | 2,693 | $90,431 | 1.75% | Long | EC | |
| Taysha Gene Therapies Inc | TSHA | 12,369 | $79,038 | 1.53% | Long | EC | |
| Biohaven Ltd | BHVN | 7,016 | $67,283 | 1.30% | Long | EC | |
| Rapport Therapeutics Inc | RAPP | 1,610 | $53,339 | 1.03% | Long | EC | |
| Bright Minds Biosciences Inc | DRUG | 539 | $47,405 | 0.92% | Long | EC | |
| Annexon Inc | ANNX | 7,048 | $41,372 | 0.80% | Long | EC | |
| Alto Neuroscience Inc | ANRO | 1,571 | $40,312 | 0.78% | Long | EC | |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | IART | 3,675 | $38,735 | 0.75% | Long | EC | |
| LB Pharmaceuticals Inc | LBRX | 1,036 | $32,852 | 0.63% | Long | EC | |
| Brainsway Ltd | BWAY | 1,869 | $30,951 | 0.60% | Long | — | |
| Ceribell Inc | CBLL | 1,337 | $26,954 | 0.52% | Long | EC | |
| Prothena Corporation PLC | PRTA | 2,392 | $26,456 | 0.51% | Long | EC | |
| Relmada Therapeutics Inc | RLMD | 3,334 | $25,072 | 0.48% | Long | EC | |
| Solid Biosciences Inc | SLDB | 3,302 | $23,973 | 0.46% | Long | EC | |
| Design Therapeutics Inc | DSGN | 1,744 | $23,718 | 0.46% | Long | EC | |
| Neuropace Inc | NPCE | 1,398 | $23,570 | 0.46% | Long | EC | |
| Regenxbio Inc | RGNX | 2,532 | $22,712 | 0.44% | Long | EC | |
| Benitec Biopharma Inc | BNTC | 1,798 | $21,666 | 0.42% | Long | EC | |
| MapLight Therapeutics Inc | MPLT | 677 | $21,576 | 0.42% | Long | EC | |
| VANDA PHARMACEUTICALS INC. | VNDA | 2,996 | $21,272 | 0.41% | Long | EC | |
| NEUROGENE INC. | NGNE | 678 | $17,689 | 0.34% | Long | EC | |
| OVID THERAPEUTICS INC. | OVID | 6,364 | $17,628 | 0.34% | Long | EC | |
| Anavex Life Sciences Corp | AVXL | 4,943 | $16,510 | 0.32% | Long | EC | |
| Entrada Therapeutics Inc | TRDA | 1,178 | $15,903 | 0.31% | Long | EC | |
| Clearpoint Neuro Inc | CLPT | 1,418 | $15,853 | 0.31% | Long | EC | |
| AC Immune SA | ACIU | 3,350 | $10,151 | 0.20% | Long | EC | |
| Alector Inc | ALEC | 4,108 | $9,736 | 0.19% | Long | EC | |
| Inhibikase Therapeutics Inc | IKT | 5,080 | $9,601 | 0.19% | Long | EC | |
| Voyager Therapeutics Inc | VYGR | 2,514 | $9,377 | 0.18% | Long | EC | |
| Larimar Therapeutics Inc | LRMR | 2,281 | $9,261 | 0.18% | Long | EC |